English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 天
Acura制药公司与AD Pharma修订协议,面临财务挑战
伊利诺伊州PALATINE讯 — Acura制药公司(OTC Market: ACUR)是一家专注于开发防滥用药物的微型制药公司,市值仅为USD 0.05百万。根据最新的SEC文件显示,该公司已与Abuse Deterrent Pharma, LLC(AD Pharma)达成修订协议。尽管该公司股票在过去六个月下跌近79%,但年初至今仍上涨300%。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
US launches strikes in Yemen
Trump signs funding bill
Sworn in as Canada's PM
Senate confirmation hearing
Plane engine catches fire
Pleads not guilty
Wins longest-ever Iditarod
Child abuse images sentence
SK: Massive rallies erupt
Withdraws nomination
Kupp signs with Seahawks
Court lifts Trump's DEI block
Top intelligence agency visit
Gold rises to new heights
Influencer leaves Australia
Permanently shuts route
Strikes deal with DOGE
Texas measles outbreak
Cuba suffers power outage
To cut 2,000+ jobs
US expels SA ambassador
Second protester arrested
ISIS leader killed in Iraq
Syed formally resentenced
Felony gun possession arrest
Coffee creamer recall
Laceration hazard recall
Chiefs sign Tillery
‘Ted Lasso’ is coming back
RU, UKR launch aerial attacks
Consumer sentiment drops
反馈